Purpose: Knowledge of the long-term clinical outcome of Raynaud's syndrome (RS), essential both for patient counselling and formulation of optimal therapeutic recommendations, is conspicuously deficient in current medical literature. We have prospectively monitored 1039 patients with RS, 118 (11.4%) for more than 10 years to determine whether initial characterization was able to predict outcome. Methods: At initial presentation, patients were divided into four groups on the basis of vascular laboratory and serologic testing results: vasospastic, serologically positive (spast, sero+) and negative (spast,sero-) and obstructive, serologically positive (obst,sero + ) and negative (obst,sero-). Results: Connective tissue disease (CTD) was present initially in 48.6% of patients with spast, sero + results and 72.9% of patients with obst, sero + results. Of the remaining patients in these groups, progression to CTD during follow-up occurred in 16.4% of patients with spast,sero + results and 30.4% of patients with obst,sero + results. In the > 10-year follow-up group, progression to CTD occurred in 81.8% of patients in the obst,sero + group. Progression to CTD occurred in 2.0% of patients in the spast,serogroup and 8.5% of patients in the obst, sero-group. Digital ulcers occurred in 15.5% of patients in the spast, sero + group, 5.2% of patients in the spast, sero-group, 55.6% of patients in the obst, sero + group, and 48.2% of patients in the obst, sero-group. Digital or phalangeal amputations were required in 1.4%, 1.6%, 11.6%, and 19.0% of these patients, respectively. Conclusions: The long-term outcome of patients with RS can be predicted by initial serologic studies and separation into vasospastic and obstructive categories. Initial serologic positivity strongly predicts the development of CTD. Initial vascular laboratory classification of obstructive RS strongly predicts digital ulcerations, which occurred in half of these patients regardless of initial serologic study results. Amputations were required in 10% to 20% of patients with obstructive RS. These occurrences did not increase with increased duration of disease. Ulcerations and amputations were rare in patients initially with vasospastic KS. (J VASC SURG 1996;23:76-86.) Digital pain and blanching caused by exposure to cold and .emotional stress was first described by Raynaud ~ in 1862. In spite of more than a century of study, Raynaud's syndrome (RS) remains a subject
valuable from a prognostic standpoint. Patients predisposed to a more benign course would benefit from reassurance, whereas knowledge of a more serious prognosis would allow the remainder to regard the syndrome with appropriately increased vigilance. We have reviewed our experience with long-term outcome of 1039 prospectively monitored patients with RS in an effort to identify prognostic variables on presentation.
METHODS
At the Oregon Health Sciences University, we have held a weekly clinic devoted to RS since 1971. Between 1971 and 1995, 1039 patients with RS were enrolled in this clinic. Initial evaluation consisted of history, physical examination, hand radiography, serologic testing, and noninvasive vascular laboratory testing. Patients were questioned specifically about onset of symptoms, inciting factors, history of ulcerations, and smoking history. Patients were asked to characterize sites of involvement, that is, hands, feet, or both. Pertinent historical data including frostbite, trauma, carpal tunnel syndrome, Buerger's disease, atherosclerosis, vibration exposure, kidney disease, malignancy, medication, and endocrine abnormalities were recorded. Patients were questioned with regard to symptoms of CTD, including arthralgias, dysphagia, and sclerodactyly. Hand radiograms were reviewed to determine calcinosis or tuft resorption.
The minimal baseline serologic examination consisted of rheumatoid factor and anti-nuclear antibody. Further serologic testing included extractable nuclear antigen, anti-ribonucleoprotein, anti-singlestrand-B, and anti-native-DNA as necessary to establish the diagnosis of a CTD. In addition, a complete blood count, sedimentation rate, and serum protein electrophoresis were obtained, and in recent years a~ hypercoagulable screen was obtained in selected patients consisting of protein C, protein S, lupus anticoagulant, antithrombin III, antiphospholipid antibody, and recently factor V resistance to activated protein C. Assays for cold agglutinins, cryoglobulins, and cryofibrinogens were also performed on selected patients. Patients were considered to have a hematologic abnormality if the results of any of the above tests, except the serologic tests, were abnormal. When CTD was suspected, rheumatologic consultation was obtained and appropriate specific tests were performed to permit CTD diagnosis according to American Rheumatologic Association criteria. [2] [3] [4] [5] [6] [7] The standard noninvasive vascular laboratory approach has changed during the course of this study. Between 1972 and 1978 the standard evaluation consisted of hand temperature recovery after cold water immersion and finger plethysmography as previously described. 8 Although close to 100% specific, the cold water test was only 50% sensitive. Since 1978, patients have undergone a hypothermic challenge with finger blood pressure measurements according to the method described by Nielsen. 9 This method is 87% specific and 90% sensitive, with an overall accuracy of 92% in our experience) ~ The diagnosis of RS was based on the patients' symptoms of digital color change and coolness with cold exposure or emotional stress confirmed by a positive Nielsen test result, although a positive Nielsen test result was not required for entry into the study population. In addition to the Nielsen test, all patients underwent measurement of finger systolic blood pressures and finger plethysmography. Measurement of finger blood pressures was performed in a warm, draft-free room. A pneumatic cuffwas placed around the proximal phalanx, with a photoplethysmograph placed over the distal phalanx. Values obtained reflect the pressure in the common and proximal proper digital arteries. The pulse contour was evaluated with photoplethysmography as previously described. 11 Representative normal and obstructive waveforms are displayed in Fig. 1 .
On the basis of the results of their noninvasive studies, patients were characterized as having vasospastic or obstructive RS. The distinction between vasospastic and obstructive RS was made at room temperature. Most patients with RS experienced an abnormal digital pressure drop with the Nielsen test. Measurement of digital artery pressures and digital plethysmography at room temperature distinguished obstructive RS from vasospastic RS. A positive Nielsen test result, blunted or peaked waveforms on plethysmography, and digital artery systolic pressures more than 20 mm Hg below brachial pressure established the diagnosis of obstructive RS.~,~2
During the early 1970s hand arteriography was part of our routine evaluation) a We have since modified this approach and now obtain upper extremity angiograms only on patients in whom there is a suspicion of a proximal arterial lesion, particularly in patients with unilateral symptoms andno evidence of a systemic disorder. 14 On the basis of initial evaluation, patients were categorized into four groups depending on their initial serologic and noninvasive study results: (1) vasospastic, serologically positive (spast,sero + ); (2) vasospastic, serologically negative (spast,sero -); (3) R E S U L T S L e n g t h o f follow-up. Between 1972 and 1994, 1039 patients with RS were evaluated in our Raynaud's clinic. Mean length of follow-up for the entire group was 3.2 years (range 0 to 21 years). One hundred eighteen (11.4%) were monitored for 10 years or more. The demographics of these two groups are presented in Table I . N o differences were present in age, sex distribution, smoking history, diabetic status, or sites of involvement.
T y p e o f RS. Five hundred eighty-five patients (56.3%) were diagnosed as having vasospastic RS. Four hundred fifty-four patients (43.7%) were diagnosed as having obstructive RS. In the > 10-year follow-up group, 50 patients (42.4%) had vasospastic RS, and 68 (57.6%) had obstructive RS. Three hundred forty-nine patients (33.6%) had initially serologically positive results. Six hundred ninety Table II . The most frequent classification among all patients was spast,sero-(42.6%). This classification was statistically less frequent in the > 10-year follow-up group (27.1%). In contrast, the obst,sero+ group, which represented 19.9% of all patients at presentation, was statistically more frequent in the > 10-year follow-up group (33.9%). The percentages of patients in the spast,sero + and obst,sero -groups were not different between all patients and the > 10-year follow-up group (13.7% vs 15.3% and 23.8% vs 23.7%, respectively).
The demographics of all patients in the four groups are shown in Table III . Patients in the spast,sero-group were younger (p < 0.001) at the time ofpresontation than all other groups. A greater percentage of male patients (p < 0.001) were present in the obst, sero-group compared with all other groups. A higher percentage of smokers was present in the two groups with obstructive RS compared with those with vasospastic RS (p < 0.05). Sites of involvement also differed between these groups (p < 0.05). Differences were also noted in mean length of follow-up, with the shortest length of follow-up in the spast, sero-group (2.7 _+ 3.9 years), the longest follow-up in the obst,sero + group (4.5 __ 5.4 years), and intermediate length of follow-up in the spast, sero + (3.2 _+ 4.5 years) and obst,sero-(3.4 -+ 4.9 years) groups. In the > 10-year follow-up group (Table IV) , the same sex differences were present between the obst, sero -group and all other groups (p < 0.05). A difference in age was present only between the spast,sero+ and spast, sero-groups (p < 0.05).
More smokers were present in the obst,sero -group compared with both groups with vasospastic RS (p < 0.01). Sites of involvement differed between the obst,sero-group and the groups with positive serologic results (p < 0.05), who were more likely to have involvement of both hands and feet. Length of follow-up differed only between the spast,serogroup and the obst,sero-group (p < 0.05).
CTD present at the time of diagnosis. At the time of initial diagnosis of RS, 48.6% of patients in the spast,sero + group and 72.9% of patients in the obst, sero + group were diagnosed with CTD (Table  V) . These percentages are the same among the comparable groups of patients in the < 10-year follow-up group (50.0% and 72.5%, respectively).
Development ofa CTD during follow-up. The percentages of patients without a CTD at initial presentation who went on to have development of a CTD are presented in Table VI . This least frequent rate of progression to CTD was in the spast,serogroup (2.0%), with the highest in the obst, sero+ group (30.4%). CTD developed in 16.4% of patients in the spast,sero+ group and 8.5% of patients without an initial CTD in the obst,sero-group. A statistically significant difference in the rate of progression was present among all groups except spast, sero + vs both groups with obstructive RS.
Of patients monitored for more than 10 years, 81.8% of the obst,sero + group withqut initial CTD had development of a CTD, an incidence that exceeded the group as a whole (p < 0.005). Progression to CTD occurred in 33.3% of patients in the spast,sero+ group, 17.9% of patients in the obst, sero-group, and 6.3% of patients in the spast, sero-group. No further differences were present lanuary 1996 between the whole group and the long-term follow-up group. Overall prevalence of CTD. Overall, CTD were diagnosed either initially or during follow-up in 279 patients (26.9%). Within the four groups, CTD were diagnosed in 81.1% of patients in the obst,sero+ group, 57.0% of patients in the spast,sero + group, 8.5% of patients in the obst,sero-, and 2.0% of patients in the spast,sero-group (Fig. 2) . Statistically significant differences were present among all groups (p < 0.001).
In the > 10-year follow-up group, CTD were diagnosed in 57 patients (48.3%). This included 95% of patients in the obst,sero + group, 66.7% of patients in the spast,sero + group, 17.9% of patients in the obst, sero-group, and 6.3% of patients in the spast,sero -group (Fig. 3) . Differences were present among all groups (p < 0.05) except between the two serologically negative groups.
Types of CTD. Of the 279 patients diagnosed with CTD, 186 had obstructive RS, which represents 43.2% of the total number of patients with obstructive RS. The remaining 93 patients had vasospastic RS, representing 16.4% of the total number of patients with vasospastic RS. The distribution of the types of CTD diagnosed is presented in Table VII . Progressive systemic sclerosis (scleroderma) was the single most frequent CTD in patients with oBstructive RS, whereas Sj6gren's syndrome and undifferentiated CTD were comparatively more frequent in patients with vasospastic RS (p--0.013, and p --0.009, respectively) with a trend for increased incidence of systemic lupus erythematosus (p --0.094). No differences in mixed CTD, rheumatoid arthritis, or unknown CTD were present. Table VIII . Ulcerations were distinctly infrequent in patients in the spast,sero-group, occurring in only 23 of 443 patients (5.2%). A history of atherosclerosis, Buerger's disease, frostbite, a hematologic abnormality, or trauma was present in 10 of these patients. No associated disease was detected in the other 13 patients. Digital ulceration was most frequently present at the time of presentation, with approximately one half of patients having recurrent ulceration during follow-up. ~s Digital ulcerations were also infrequent in patients in the spast,sero + group, occurring in 22 of la8 patients (15.9%). CTD was presenf in 18 of these patients. In the remaining Ibur patients, either Buerger's disease, frostbite, or a hematologic abnormality was present.
Digital ulcerations occurred in 119 of 247 (48.2%) patients in the obst, sero-group. Associated diseases in this group included atherosclerosis in 20 patients, Buerger's disease in 24, a hematologic abnormality in 16, rapid onset digital artery occlusion as a result of hypersensitivity angiitis or emboli from a proximal source in 12, and a history of frostbite in 6. Ten patients had a history of either malignancy, carpal tunnel syndrome, trauma, or vibration exposure. No cause was recognized in the remaining 31 patients. One hundred fifteen of 207 (55.6%) patients in the obst,sero + group had development of ulcers. Ninety-six of these (83.5%) had a CTD. Nineteen (16.1%) had positive serologic results only without evidence of CTD. Associated diseases were present in 19 of the 96 patients with CTD (carpal tunnel syndrome in six, hypothyroidism in five, cancer in four, atherosclerosis, hematologic abnormality, frostbite, and trauma in one each). Nine of the 19 with positive serologic results only had associated diseases (rapid onset digital artery occlusion, hematologic abnormality, and atherosclerosis in two each, carpal tunnel syndrome, hypothyroidism, and Buerger's disease in one each).
Differences were present among each of the four groups (p < 0.001) except obst,sero+ versus obst, sero --.
In the group of patients monitored greater than 10 years, digital ulcers occurred in 27.7% of patients in the spast, sero+ group, 6.3% of patients in the spast,sero, group, 52.5% of patients in the obst, sero+ group, and 53.6% of patients in the obst, sero-. Differences were present between the spast, sero -group versus both groups with obstructive RS (p < 0.001). No differences in ulcer prevalence were present in any of the four patient groups when the whole group was compared with the > 10-year follow-up group.
Digital or phalangeal amputations. Digital or phalangeal amputations (Table IX) were rarely required in patients with vasospastic RS. Only 1.4% of patients in the spast,sero+ group and 1.6% of patients in the spast,sero-group required amputations, with no difference between these groups. Amputations were required in 11.6% of patients in the obst, sero + group and 19.0% of patients in the obst,sero-group. Again, no difference was present between these groups. Statistical significance was achieved (p < 0.005) when either of the groups with vasospastic RS was compared with either of the groups with obstructive RS.
In the > 10-year follow-up group, amputations were required in none of the patients in the spast, sero+ group, 6.3% of the patients in the spast, sero-group, 20.0% of the patients in the obst, sero+ group, and 25.0% of the patients in the obst, sero-group. Although there was a trend toward more amputations in the patients with obstructive RS, no comparisons reached statistical significance. Likewise, no differences were present among all patients and the > 10-year follow-up group for any of the four patient categories. Unlike ulceration, amputation was rarely performed at admission to the study but frequently was performed within 1 year of study initiation.
DISCUSSION
RS remains an enigmatic medical condition despite more than a century of research on this subject. RS is estimated to affect between 3.5% and 25% of the male population and between 5% and 30% of the female population in cool, damp climates,9-~2 and it is frequently encountered by many physicians, including vascular surgeons. 1619 Our interest in this condition has resulted in the accumulation of a database of more than 1000 patients over a 24-year period representing a broad specti-um of disease severity. In this study we have attempted to characterize the long-term clinical outcome of these patients and, on the basis of an initial evaluation including both vascular laboratory and serologic data, to establish the predictive likelihood of disease progression, including CTD, digital ulcerations, and digital amputations.
Our method of classification of RS differs from the traditional system established in the 1930s by Allen and Brown 2~ who divided RS into Raynaud's phenomenon and Raynaud's disease on the basis of the absence or presence of an associated disease. However, as early as the 1950s, it was recognized that Raynaud's phenomenon may precede an underlying disease by many yearsfl 1 Thus from a prognostic standpoint the traditional classification is of limited use, and we have chosen to classify all patients with cold-o/" stress-induced digital ischemia as having RS. Nonetheless, it is clear that all patients diagnosed with symptoms of digital ischemia are not the same, and important distinctions are helpful, ideally at the time of initial diagnosis. We have divided patients into four groups according to whether they have evidence of digital vasospasm or obstruction and whether they have positive or negative serologic results.
The most frequent group in the overall database were patients with negative serologic results and digital artery vasospasm. In the > 10-year follow-up group, however, patients with obstructive symptoms and positive serologic results were more frequent. This is explained in part by differences in disease severity. Patients in the spast,sero-group typically have less severe disease and are therefore less likely to return for long-term follow-up, whereas in the obst,sero + group the opposite holds true.
The association between RS and the subsequent development of a CTD has been well established for years. Gifford and Hines, 2~ reporting on their experience from the Mayo Clinic in the 1950s, found a 4.6% progression to a CTD in 280 patients monitored for more than 2 years; however, no subclassification of RS was done. Several recent smaller studies have addressed the likelihood of CTD development in patients with RS. In patients with no clinical or serologic abnormalities, progression to CTD occurred in up to 9% in series consisting of 16 to 78 patients with mean follow-up of 2 to 6 years. 22-s~ The corresponding group in our study was the spast,sero -group, consisting of 443 patients, 32 of whom were monitored greater than 10 years. Progression to a CTD occurred in 2% of the whole group and 6.3% among those monitored greater than 10 years, which is consistent with prior studies of patients with RS.
The risk of a subsequent diagnosis of a CTD in patients with RS and one or more serologic or clinical abnormalities is more variable. In studies ranging from nine to 35 patients, progression to a CTD ranged from 11% to 65%. ls-2s In our study the rate of progression depended on the nature of the initial abnormality. Two hundred forty-seven patients, 28 monitored more than 10 years, had clinical evidence of digital obstruction at the time of diagnosis without serologic abnormality; 8.5% of this group and 17.9% of the long-term follow-up group went on to have development of a CTD. The rate of progression is much greater if initial serologic results are positive. In the 142 patients with vasospastic RS and positive serologic results, 48.6% had a CTD at the time of diagnosis, and of the remaining patients, 16.4% of the entire group and 33.3% of the long-term follow-up group went on to have development of CTD. Patients with obstructive RS and positive serologic results had a 72.9% prevalence of CTD initially. Of the remaining 27.1%, 30.4% of the whole group and 81.8% of the long-term follow-up group went on to have development of CTD. Very few studies have addressed the issue of progression to ulcerations and amputations in patients with RS. In an initial study from our institution of 44 patients monitored more than 10 years with evidence of digital artery obstruction documented by angiography at the time of presentation, 58% of patients with initial ulcerations had development of recurrent ulcerations, and 15% required amputations. 24 It is generally believed that primary vasospastic RS is a benign disease constituting little more than a nuisance condition. Our study generally supports this view. In the 443 patients in the spast,sero-group, digital ulcerations developed in 5.2% (6.3% in the long-term follow-up group), and amputations were required in 1.6% of patients (6.3% in the long-term follow-up group). Given the benign nature, of this disease, it was surprising that ulcers or "amputations occurred in any of this subset. However, further analysis revealed that most of this small group proceeded to have development of conditions associated with digital artery obstruction, that is, atherosclerosis and Buerger's disease, which may have been undetectable by vascular laboratory evaluation. Janua~, 1996 Again, in patients with serologic or vascular laboratory abnormalities, progression to ulcers and amputations depended on the nature of the abnormality. Patients with vasospastic RS and positive serologic results had development of ulcers in 15.5 % of patients (27.7% of the long-term follow-up group), but amputations were rare. Almost all of these patients either had a CTD initially or had development of one during follow-up.
In patients with obstructive RS, progression to ulceration and amputation was the same regardless of whether serologic abnormalities were present. Ulcerations were present in approximately 50% of each group, and phalangeal amputations were required in 10% to 20%. The reasons for ulcerations and amputations were different in these two groups. Patients with positive serologic results most likely had a CTD, of which scleroderma was particularly virulent. Patients with negative serologic results were more likely to have Buerger's disease, atherosclerosis, or rapid onset digital artery obstruction from a variety of causes, most frequently hypersensitivity angiitis, a hypercoagulable state, or digital artery emboli from a proximal source. In the patient group studied, patients in the obst,sero + and obst,serogroups had a similar outcome.
Interestingly, no differences were noted between the group as a whole and those monitored longer than 10 years in the development of ulcerations and the need for digital or phalangeal amputations. This suggests that these are problems that arise early in the course of the disease. If patients have had RS for greater than 10 years and have not had problems with ulcerations or amputations, in our experience it is unlikely that they will have subsequent development of them.
Patients with RS frequently are evaluated with similar symptoms regardless of the underlying cause. For most of these patients, the symptoms are easily controlled with minimal intervention and with rare adverse sequelae. Clearly, however, a subset of patients will have development of more severe symptoms and may require phalangeal amputations. The early ability to predict which patients will fall into these categories is of considerable importance for patient counselling. Because our university is a tertiary care center that is frequently referred the most severe cases, it is unclear whether our overall experience reflects that of the general population. However, it does appear that categorization of patients into the above-mentioned groups at the time of initial presentation does provide both the patient and the referring physician with important prognostic information. In 1932 Allen and Brown 2~ used clinical observations in tile first 2 years to separate a benign, primary Raynaud's disease from Raynaud's phenomenon as a result of other causes, most commonly scleroderma. Their concept remains valid, but their terminology has always been cumbersome. In the 1950s and 1960s, late crossover from the primary group was noted to increase by Gifford and Hines 21 and others as our knowledge of CTDs matured.
The last three decades have more fully defined hematologic and immunologic mechanisms. Angiography and the vascular laboratory provide accurate measurement of spasm and of obstruction. All are incorporated in this study. It has the broadest base extant, it is prospective, and it has excellent~ I want to condense these extensive data into three useful clinical groupings. The nonobstructive seronegative group is the largest, and it documents the existence of a primary, benign RS. Only 2% later cross over to other secondary causes, and many of these are identified as coincidental events in the text.
The seropositive group, with or without obstruction, declares secondary Raynaud's, with a high incidence of CTD initially and later, and it defines other syndromes whose behavior and treatment is quite possible. This group requires regular follow-up because of significant late crossover.
Finally, the patients in the obst,sero-group are predominantly male, have a high incidence of requiring amputation, and they have the broadest spectrum of causes clearly outlined in the text. Many of these are common to the vascular surgical practice. Both a vigorous initial investigation and regular follow-up are necessary for the group.
Does your experience include drugs, thoracic outlet syndromes, and occupational palmar disease as causes of Raynaud's phenomenon?
You use the term atherosclerosis in a generic sense. Could you define the specific lesions such as aneurysms, proximal disease, macroemboli, and microemboli that might be responsible? Do you have any data defining the effect of cessation of tobacco use on the course of RS? Would you comment on the value of nail bed microscopy in the differentiation of secondary RS still commonly used in Europe?
Dr. Gregory J. Landry. With respect to the question regarding drugs, thoracic outlet syndrome, and palmar occupational occlusive disease, our experience indicates that patients with all of the above-mentioned disorders are rare and therefore were not included in our study.
The term atherosclerosis was applied to patients with obstructive RS with any type of generalized atherosclerosis in whom no other cause of digital artery obstruction could be detected.
With regard to cessation of tobacco use, we recognize that patients with obstructive RS from causes such as Buerger's disease and atherosclerosis benefi~ from cessationof tobacco use. We are not aware of any connection between patients with generalized vasospastic RS and history of smoking.
Nail bed microscopy has been used by many people to evaluate patients for the development of scleroderma. We are not aware that nail bed microscopy can be used for other types of CTDs other than scleroderma, however, nor can be it be used for patients with other types of obstructive RS such as Buerger's disease and atherosclerosis. In centers where this technology is available, it has been used with success; however, we do not perform this technique at our institution.
Dr. Geun-Eun Kim (New York, N.Y.). Did the patient who eventually had development of CTD during your follow-up receive steroid treatment? As you know, steroids can affect arterial wall lesion beneficially or adversely.
Dr. Landry. I'm not aware whether patients were treated with steroids among the patients with CTDs. Many of these patients are seen in conjunction with the rheumatologists and internists. Our specific duty is to treat their symptoms of RS, and I'm not aware of the percentages of patients with CTDs who were treated with steroids.
Dr. Harry B. Abrarnowitz (Jerusalem, Israel). Because the critical separation is between the spastic and the obstructive group, other than stating that you're using blood pressure studies and plethysmographic studies, what specifically are you using for your noninvasive determination?
Dr. Landry. With regard to digital blood pressures, we regard a patient as having obstructive KS if there is a difference greater than 20 mm Hg between the brachial and digital blood pressure.
With regard to digital plethysmography, we looked for dampening in the plethysmographic waveforms, specifically with delayed upstroke and blunting of the peak of the waveform.
Dr. Jack L. Cronenwett (Lebanon, N.H.). It's been said that ulcers never develop in patients in the spast,serogroup, and even in this series it rarely happened. But why did 5% have development of ulceration?
Dr. Landry. We too were quite curious about why any of these patients had any adverse sequelae, and we studied this group of patients quite extensively and found that these patients went on to have development of some type of an obstructive process later in the course of their disease, specifically either Buerger's disease, some type of atherosclerotic or embolic lesion, or some other type of obstructive process that was not present at their initial evaluation. It may actually have been present but was not detected with our vascular laboratory methods. So in short, these are patients who subsequently went on to have development of some type of obstructive process that was not detected initially.
Dr. Thomas L. Whitsett (Oklahoma City, Okla.). Many patients are said to have RS who have some other type of vasospastic phenomenon. What criteria did you use to include these people in that category?
Dr. Landry. We consider all patients admitted with either cold-or stressed-induced symptoms of digital artery ischemia as having RS. Approximately 90% of these patients will have their symptoms verified by a Nielsen test. We find that 10% of these patients, however, will not have a positive Nielsen test result; but because of the nature of their symptoms, we include them in the classification of patients with vasospastic KS.
1-800-55-MOSBY
This number links you to the full text of articles published in more than 25,000 journals, including all Mosby journals. MOSBY Document Express, | a rapid response information retrieval service, provides quick turnaround, 24-hour availability, and speedy delivery methods. For inquiries and pricing information, call our toll-free, 24-hour order line: 1-800-55-MOSBY; outside the United States: 415-259-5046; fax: 415-259-5019; E-mail: mosbyexp@class.org.
MOSBY Document Express ~ is offered in cooperation with Dynamic Information Corp.

